BENJAMIN F. EDWARDS & COMPANY, INC. - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
BENJAMIN F. EDWARDS & COMPANY, INC. ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2022$5,000
-78.3%
100
-71.9%
0.00%
-100.0%
Q1 2022$23,000
-76.3%
356
-60.7%
0.00%
-75.0%
Q4 2021$97,000
+24.4%
906
+19.8%
0.00%0.0%
Q3 2021$78,000
+2500.0%
756
+1790.0%
0.00%
Q3 2019$3,000
-25.0%
400.0%0.00%
Q2 2019$4,000
+33.3%
400.0%0.00%
Q1 2019$3,000
+50.0%
400.0%0.00%
Q4 2018$2,000
-33.3%
400.0%0.00%
Q3 2018$3,000400.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders